Anna Sunshine completed her medical school, graduate school and psychiatry training at the University of Washington. Her graduate training was completed in the Department of Genome Sciences where she used high-throughput sequencing approaches to study the biological effects of complex genetic changes in the model organism Saccharomyces cerevisiae.
Connecting her background in genomics with psychiatry, Dr. Sunshine’s research now focuses on identifying genetic risk factors for schizophrenia and characterizing the biological effects of these risk alleles using induced pluripotent stem cell (iPSC) systems. Dr. Sunshine engages individuals living with schizophrenia and their families in research to further our current understanding of schizophrenia biology and help lay groundwork for future treatment development.
Psychiatry Residency, University of Washington, 2020
MD, University of Washington, 2016
PhD, University of Washington, 2014
(2023 Nov 16)
McClellan JM, Zoghbi AW, Buxbaum JD, Cappi C, Crowley JJ, Flint J, Grice DE, Gulsuner S, Iyegbe C, Jain S, Kuo PH, Lattig MC, Passos-Bueno MR, Purushottam M, Stein DJ, Sunshine AB, Susser ES, Walsh CA, Wootton O, King MC
J Child Psychol Psychiatry 64(7): 980-988
Sunshine A, McClellan J
PLoS Genet 13(2): e1006585
Sanchez MR, Miller AW, Liachko I, Sunshine AB, Lynch B, Huang M, Alcantara E, DeSevo CG, Pai DA, Tucker CM, Hoang ML, Dunham MJ
PLoS Genet 12(10): e1006339
Payen C, Sunshine AB, Ong GT, Pogachar JL, Zhao W, Dunham MJ
Aging Cell 15(2): 317-24
Sunshine AB, Ong GT, Nickerson DP, Carr D, Murakami CJ, Wasko BM, Shemorry A, Merz AJ, Kaeberlein M, Dunham MJ
Show complete publication list »